NDLI: Underreporting of myeloid malignancies by United States cancer registries.

Please wait, while we are loading the content...

Tumor suppressor function of PGP9.5 is associated with epigenetic regulation in prostate cancer--novel predictor of biochemical recurrence after radical surgery.

Associations between genes in the one-carbon metabolism pathway and advanced colorectal adenoma risk in individuals with low folate intake.

Vitamin D and calcium supplementation and one-year change in mammographic density in the women's health initiative calcium and vitamin D trial.

Common variation in Nemo-like kinase is associated with risk of ovarian cancer.

Nitrosamines and heme iron and risk of prostate cancer in the European prospective investigation into cancer and nutrition.

Vasoactive peptides with angiogenesis-regulating activity predict cancer risk in males.

Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk.

Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes.

The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--point.

The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--counterpoint.

Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death.

Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.

Light exposure and melatonin among rotating shift nurses--letter.

Year: 2012 Volume: 21 Issue: 2

Year: 2012 Volume: 21 Issue: 1

Year: 2011 Volume: 20

Year: 2010 Volume: 19

Year: 2009 Volume: 18

Year: 2008 Volume: 17

Year: 2007 Volume: 16

Year: 2006 Volume: 15

Year: 2005 Volume: 14

Year: 2004 Volume: 13

Year: 2003 Volume: 12

Underreporting of myeloid malignancies by United States cancer registries.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Craig, Benjamin M. Rollison, Dana E. List, Alan F. Cogle, Christopher R.
Spatial Coverage	United States
Description	Country affiliation: United States Author Affiliation: Craig BM ( H.Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA. benjamin.craig@moffitt.org)
Abstract	BACKGROUND: The recent decrease in myeloid leukemia incidence may be directly attributed to changes in the population-based cancer registries 2001 guidelines, which required the capture of only one malignancy in the myeloid lineage per person and the simultaneous adoption of myelodysplastic syndrome registration in the United States. METHODS: We constructed four claims-based algorithms to assess myeloid leukemia incidence, applied the algorithms to the 1999-2008 Surveillance Epidemiology and End Results (SEER)-Medicare database, and assessed algorithm validity using SEER-registered cases. RESULTS: Each had moderate sensitivities (75%-94%) and high specificities (>99.0%), with the 2+BCBM algorithm showing the highest specificity. On the basis of the 2+BCBM algorithm, SEER registered only 50% of the acute myelogenous leukemia cases and a third of the chronic myelogenous leukemia (CML) cases. The annual incidence of myeloid leukemia in 2005 was 26 per 100,000 persons 66 years or older, much higher than the 15 per 100,000 reported by SEER using the same sample. CONCLUSION: Our findings suggest underreporting of myeloid leukemias in SEER by a magnitude of 50% to 70% as well as validate and support the use of the 2+BCBM claims algorithm in identifying myeloid leukemia cases. Use of this algorithm identified a high number of uncaptured myeloid leukemia cases, particularly CML cases. IMPACT: Our results call for the commitment of more resources for centralized cancer registries so that they may improve myeloid leukemia case ascertainment, which would empower policy makers with ability to properly allocate limited health care resources.
File Format	HTM / HTML
ISSN	10559965
e-ISSN	15387755
DOI	10.1158/1055-9965.EPI-11-1087
Journal	Cancer Epidemiology Biomarkers & Prevention
Issue Number	3
Volume Number	21
Language	English
Publisher	American Association for Cancer Research
Publisher Date	2012-03-01
Publisher Place	United States
Access Restriction	Open
Subject Keyword	Discipline Cancer epidemiology Leukemia, Myeloid Epidemiology Myelodysplastic Syndromes Myeloproliferative Disorders Algorithms Bias (epidemiology) Insurance Claim Review Medicare Retrospective Studies Risk Assessment Seer Program Sensitivity And Specificity Research Support, N.i.h., Extramural
Content Type	Text
Resource Type	Article
Subject	Epidemiology Oncology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Underreporting of Myeloid Malignancies by United States Cancer Registries

Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies.

Inflammasome Activation in Myeloid Malignancies—Friend or Foe?

Metabolic syndrome and risk of endometrial cancer in the united states: a study in the SEER-medicare linked database.

The role of mutations in epigenetic regulators in myeloid malignancies.

Editorial: Uncovering the relationship between myelodysplastic syndromes and acute myeloid leukemia

RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.

Reduced-intensity conditioning transplantation in myeloid malignancies.

Loss of heterozygosity identifies genetic changes in chronic myeloid disorders, including myeloproliferative disorders, myelodysplastic syndromes and chronic myelomonocytic leukemia

Underreporting of myeloid malignancies by United States cancer registries.

Similar Documents

Underreporting of Myeloid Malignancies by United States Cancer Registries

Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies.

Inflammasome Activation in Myeloid Malignancies—Friend or Foe?

Metabolic syndrome and risk of endometrial cancer in the united states: a study in the SEER-medicare linked database.

The role of mutations in epigenetic regulators in myeloid malignancies.

Editorial: Uncovering the relationship between myelodysplastic syndromes and acute myeloid leukemia

RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.

Reduced-intensity conditioning transplantation in myeloid malignancies.

Loss of heterozygosity identifies genetic changes in chronic myeloid disorders, including myeloproliferative disorders, myelodysplastic syndromes and chronic myelomonocytic leukemia

Underreporting of myeloid malignancies by United States cancer registries.